风湿性疾病患者围妊娠期药物使用规范

Recommendations for the medication of rheumatic diseases in periconceptional period

风湿性疾病是一大类主要累及关节及其周围组织的慢性炎症性疾病,大多数情况下患者需长期药物治疗,妊娠期用药难以避免。风湿性疾病患者在妊娠期的药物选择需兼顾疗效与母亲、胎儿的安全性。中华医学会风湿病学分会组织国内有关专家,在借鉴国内外相关领域的指南、共识、诊疗经验的基础上制定了本规范,对风湿性疾病常用药物在备孕期、妊娠期和哺乳期的应用与注意事项提出建议,旨在规范风湿性疾病围妊娠期的药物使用。

Rheumatic diseases are a kind of chronic inflammatory diseases mainly involving joints and surrounding tissues.Most patients with rheumatic diseases need long-term treatment,which is difficult to be avoided during pregnancy.Treatment efficacy,as well as maternal and fetal safety should be taken into account in the medical decision.Based on the domestic and foreign guidelines,consensus,diagnosis and treatment experience,Chinese Rheumatology Association developed the standardization of medication use in patients with rheumatic diseases preparing and during pregnancy,aiming on the application and precautions of commonly used medicines for rheumatic diseases in preparing pregnancy,pregnancy and lactation.